Image may be NSFW.
Clik here to view.
Sanofi (NYSE:SNY) said at the start of April that it promoted Bill Sibold to exec VP of Sanofi Genzyme, effective July 1, 2017. Sibold succeeds Dr. David Meeker, who is slated to leave the company at the end of June.
Sibold is the head of Sanofi Genzyme’s global multiple sclerosis, oncology and immunology organization. He led the company in preparation for the global launches of Dupilumab and Sarilumab. He joined Sanofi in 2011 as head of the MS business.
Get the full story at our sister site, Drug Delivery Business News.
The post Sanofi promotes Sibold to exec VP of Sanofi Genzyme | Personnel Moves – April 13, 2017 appeared first on MassDevice.
